Related content

Characterization of a Recombinant Chimeric Plasminogen Activator Composed of Gly-Pro-Arg-Pro Tetrapeptide and Truncated Urokinase-Type Plasminogen Activator Expressed in Escherichia coli

By Hua Z.C.   Chen X.C.   Dong C.   Zhu D.X.  

Biochemical and Biophysical Research Communications, Vol. 222, Iss. 2, 1996-05 ,pp. : 576-583

Elsevier

Access to resources Recommend Favorite

Suppression of Type I Collagenase Expression by Antisense RNA in Melanoma Cells Results in Reduced Synthesis of the Urokinase-Type Plasminogen Activator Receptor

By Durko M.   Brodt P.  

Biochemical and Biophysical Research Communications, Vol. 247, Iss. 2, 1998-06 ,pp. : 342-348

Elsevier

Access to resources Recommend Favorite

Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours

By Schmitt Manfred   Magdolen Viktor   Sperl Stefan   Muehlenweg Bernd   Harbeck Nadia  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 4, 2001-07 ,pp. : 683-691

Informa Healthcare

Access to resources Recommend Favorite

An Efficient System for Production of Recombinant Urokinase-Type Plasminogen Activator

By Tang W.   Sun Z.Y.   Pannell R.   Gurewich V.   Liu J.N.  

Protein Expression and Purification, Vol. 11, Iss. 3, 1997-12 ,pp. : 279-283

Academic Press

Access to resources Recommend Favorite

Crystals of the Urokinase Type Plasminogen Activator Variant &bgr;c-uPA in Complex with Small Molecule Inhibitors Open the Way towards Structure-based Drug Design

By Zeslawska E.   Schweinitz A.   Karcher A.   Sondermann P.   Sperl S.   Stürzebecher J.   Jacob U.  

Journal of Molecular Biology, Vol. 301, Iss. 2, 2000-08 ,pp. : 465-475

Academic Press

Access to resources Recommend Favorite